Pharmacokinetics of midazolam in critically ill pediatric patients.
Eur J Drug Metab Pharmacokinet
; 25(3-4): 219-21, 2000.
Article
em En
| MEDLINE
| ID: mdl-11420893
ABSTRACT
Midazolam is frequently used to produce sedation in critically ill pediatric patients. We studied the pharmacokinetics of midazolam in 22 patients (age 8 days to 16 years). The intravenous infusion rate to produce sedation ranged from 49-385 mcg/kg/hr. The blood samples were obtained at steady-state and midazolam was measured by gas chromatography with electron capture. The steady-state plasma concentrations of midazolam ranged from 49-385 ng/mL. The total clearance, apparent volume of distribution, and elimination half-life ranged from 0.1-3.1 L/kg/hr, 0.2-3.5 L/kg, and 0.3-10.9 hours, respectively. The marked interpatient variability in pharmacokinetics explains in part, the substantial variation in dosage requirements of midazolam to produce sedation in critically ill pediatric patients.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Midazolam
/
Hipnóticos e Sedativos
Limite:
Adolescent
/
Child
/
Child, preschool
/
Humans
/
Infant
/
Newborn
Idioma:
En
Revista:
Eur J Drug Metab Pharmacokinet
Ano de publicação:
2000
Tipo de documento:
Article
País de afiliação:
Estados Unidos